The sequence of the latent membrane protein 1 (LMP- 1) gene was analysed in Epstein-Barr virus (EBV) isolates from specific regions representing both type 1 and type 2 EBV. A predominant strain marked by an XhoI restriction enzyme polymorphism (REP) within the LMP-1 gene has been identified in type 1 EBV in nasopharyngeal carcinoma (NPC) from Southern China. This polymorphism was also present in type 2 EBV in NPC from Alaska. In this study, the sequence of the LMP-1 gene was determined in these samples representing type 1 and type 2 EBV and was compared with the prototype lymphoid strains. Consistent nucleotide variation in the amino terminus of LMP-1 was identified in strains marked by the XhoI REP. These changes were present in both EBV type 1 and type 2 strains. Three types of sequence variation were detected in the carboxy terminus of LMP-1. The LMP-1 sequences differed in the number of an 11 amino acid repeat element. In the prototype EBV type 1 (B95-8) sequence and in the type 1 Raji and type 2 HR-1 strains, the third repeat element contained an insertion of 5 amino acids that were also the first five unique amino acids after the last partial repeat element. The third variation was a deletion of amino acids 343 to 352 of the B95-8 LMP-1. This deletion was detected in the type 1 Chinese EBV strains, but was not detected in the type 2 Alaskan strains although the Chinese and Alaskan strains have nearly identical amino acid changes at the amino terminus. Numerous other amino acid changes were detected in the carboxy terminus which did not cosegregate with either EBV type, amino acid changes in the amino terminus, or specific geographic regions. These data indicate that EBV strains can be distinguished by sequence differences within LMP-1 and that unlike the divergence between type 1 and type 2 EBV in Epstein-Barr nuclear antigen sequences, different EBV types are nearly identical in LMP-1 sequence.
BussonP.,
GanemG.,
FloresP.,
MugneretF.,
ClausseB.,
CaillouB.,
BrahamK.,
WakasugiH.,
LipinskiM.,
TurszT.1988; Establishment and characterization of three transplantable EBV-containing nasopharyngeal carcinomas. International Journal of Cancer 42:599–606
ChenM.,
TsaiC.-N.,
LiangC.-L.,
ShuC.-H.,
HuangC.-R.,
SulitzeanuD.,
LiuS.-T.,
ChangY.-S.1992; Cloning and characterization of the latent membrane protein (LMP) of a specific Epstein-Barr virus variant derived from the nasopharyngeal carcinoma in the Taiwanese population. Oncogene 7:2131–2140
CohenJ.,
WangF.,
MannickJ.,
KieffE.1989; Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation. Proceedings of the National Academy of Sciences, U.S.A 86:9558–9562
de Campos-LimaP.-O.,
GavioliR.,
ZhangQ.,
WallaceL.,
DolcettiR.,
RoweM.,
RickinsonA.,
MasucciM.1993; HLA-A11 epitope loss isolates of Epstein-Barr virus from a highly All + population. Science 260:98–100
FennewaldS.,
van SantenV.,
KieffE.1984; Nucleotide sequence of an mRNA transcribed in latent growth-transforming virus infection indicates that it may encode a membrane protein. Journal of Virology 51:411–419
GavioliR.,
KurillaM.,
de Campos-LimaP.-O.,
WallaceL.,
DolcettiR.,
MurrayR.,
RickinsonA.,
MasucciM.1993; Multiple HLA All-restricted cytotoxic T-lymphocyte epitopes of different immunogenetics in the Epstein-Barr virus-encoded nuclear antigen 4. Journal of Virology 67:1572–1578
HuL.-F.,
ZabarovskyE. R.,
ChenF.,
CaoS.-L.,
ErnbergI.,
KleinG.,
WinbergG.1991; Isolation and sequencing of the Epstein-Barr virus BNLF-1 (LMP1) from a Chinese nasopharyngeal carcinoma. Journal of General Virology 72:2399–2409
KayeK.,
IzumiK.,
KieffE.1993; Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proceedings of the National Academy of Sciences, U.S.A 90:9150–9154
KnectH.,
BachmannE.,
BroussetP.,
SandvejK.,
NadalD.,
BachmannF.,
OdermattB. F.,
DelsolG.,
PallesenG.1993; Deletions within the LMP1 oncogene of Epstein-Barr virus are clustered in Hodgkin’s disease and identical to those observed in nasopharyngeal carcinoma. Blood 82:2937–2942
MoorthyR.,
Thorley-LawsonD.1993; Biochemical, genetic, and functional analyses of the phosphorylation sites on the Epstein-Barr virus-encoded oncogenic latent membrane protein LMP-1. Journal of Virology 67:2637–2645
NonoyamaM.,
PaganoJ.1973; Homology between Epstein-Barr virus DNA and viral DNA from Burkitt’s lymphoma and nasopharyngeal carcinoma determined by DNA-DNA reassociation kinetics. Nature; London: 24244–47
Raab-TraubN.,
FlynnK.,
PearsonG.,
HuangA.,
LevineP.,
LanierA.,
PaganoJ.1987; The differentiated form of nasopharyngeal carcinoma contains Epstein-Barr virus DNA. International Journal of Cancer 39:25–29
RickinsonA.,
YoungL.,
RoweM.1987; Influence of the Epstein-Barr virus nuclear antigen EBNA2 on the growth phenotype of virus-transformed B cells. Journal of Virology 61:1310–1317
RoweM.,
EvansH. S.,
YoungL. S.,
HennessyK.,
KieffE.,
RickinsonA. B.1987; Monoclonal antibodies to the latent membrane protein of Epstein-Barr virus reveal heterogeneity of the protein and inducible expression in virus-transformed cells. Journal of General Virology 68:1575–1586
RoweM.,
YoungL.,
CadwalladerK.,
PettiL.,
KieffE.,
RickinsonA.1989; Distinction between Epstein-Barr virus type-A (EBNA-2A) and type-B (EBNA-2B) isolates extends to the EBNA-3 family of nuclear proteins. Journal of Virology 63:1031–1039
SampleJ.,
YoungL.,
MartinB.,
ChatmanE.,
RickinsonA.,
KieffE.1990; Epstein-Barr virus type 1 and type 2 differ IN their EBNA-3A, EBNA-3B and EBNA-3C genes. Journal of Virology 64:4084–4092
SampleJ.,
KieffE. F.,
KieffE. D.1994; Epstein-Barr virus types 1 and 2 have a nearly identical LMP-1 transforming genes. Journal of General Virology 75:2741–2746
WangD.,
LiebowitzD.,
WangF.,
GregoryC.,
RickinsonA.,
LarsonR.,
SpringerT.,
KieffE.1988; Epstein-Barr virus latent infection membrane protein alters the human B-lymphocyte phenotype: deletion of the amino terminus abolishes activity. Journal of Virology 62:4173–4184
WilsonJ.,
WeinbergW.,
JohnsonR.,
YuspaS.,
LevineA.1990; Expression of the BNLF-1 oncogene of Epstein-Barr virus in the skin of transgenic mice induces hyperplasia and aberrant expression of keratin 6. Cell 61:1315–1327
YoungL.,
AlfieriC.,
HennessyK.,
EvansH.,
O’HaraC.,
AndersonK.,
RitzJ.,
ShapiroR.,
RickinsonA.,
KieffE.,
CohenJ.1989; Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. The New England Journal of Medicine 321:1080–1085